title: New liposomal cytarabine formulation in CSF.
authors.forename: P
authors.initials: P
authors.lastname: Casado
authors.forename: C
authors.initials: C
authors.lastname: Torreira
authors.forename: E
authors.initials: E
authors.lastname: Oujo
authors.forename: P
authors.initials: P
authors.lastname: Esteban
authors.forename: C
authors.initials: C
authors.lastname: Albo
authors.forename: R
authors.initials: R
authors.lastname: Diaz
authors.forename: M A
authors.initials: MA
authors.lastname: Andrade
mesh_terms: D000368:Aged; D003561:Cytarabine / Q000008:administration & dosage / Q000134:cerebrospinal fluid* / Q000627:therapeutic use*; D006801:Humans; D007276:Injections, Intraventricular; D007278:Injections, Spinal; D008081:Liposomes; D008223:Lymphoma / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008581:Meningitis / Q000188:drug therapy* / Q000209:etiology; D055815:Young Adult
chemical_list: D008081:Liposomes; D003561:Cytarabine